b
r
c
r
c
l
e
n
f
major
goal
biomed
research
clinic
revers
caus
diseas
rather
treat
symptom
gene
therapi
potenti
meet
goal
discoveri
rna
interfer
rnai
lead
new
class
highli
select
therapeut
howev
initi
enthusiasm
reduc
due
safeti
concern
associ
virusbas
deliveri
vector
use
vivo
deliveri
viral
vector
sirna
deliveri
target
cell
use
high
target
specif
deliveri
efficaci
endosom
escap
recent
discoveri
suggest
special
form
nanos
lipid
vesicl
call
exosom
incorpor
transport
function
rna
target
cell
may
serv
attract
altern
evid
accumul
pluricellular
organ
sustain
exosomebas
commun
via
intercellular
exchang
mrna
mirna
cell
discov
virus
found
way
exploit
commun
pathway
argu
adapt
exosom
impos
virus
mayb
exploit
superior
deliveri
rna
vivo
discuss
recent
discoveri
exosom
biogenesi
physic
properti
target
deliveri
strategi
knowledg
exosom
product
viru
infect
cell
could
propel
entri
clinic
set
success
implement
genet
materi
new
therapeut
tool
reli
larg
degre
appropri
deliveri
system
effici
deliveri
current
method
still
remain
low
mani
clinic
applic
rais
seriou
safeti
concern
experiment
clinic
trial
therefor
new
deliveri
agent
need
combin
high
degre
target
specif
effici
function
deliveri
minim
immunogen
ideal
carrier
could
easili
load
therapeut
cargo
choic
eg
nucleic
acid
protein
drug
first
step
toward
effici
therapeut
deliveri
sirna
microrna
mirna
upon
incorpor
carrier
vesicl
favor
advanc
drug
deliveri
review
abbrevi
abc
atpbind
cassett
ago
argonaut
appcleav
enzym
bbb
blood
brain
barrier
dex
dendrit
cellderiv
exosom
ebv
epsteinbarr
viru
ee
earli
endosom
escrt
endosom
sort
complex
requir
transport
hcc
hepatocellular
carcinoma
ilv
intralumen
vesicl
imdc
immatur
dendrit
cell
imdex
immatur
dendrit
cellderiv
exosom
lcl
latenc
type
iii
lymphoblastoid
b
cell
line
le
late
endosom
latent
membran
protein
mdex
matur
dendrit
cellderiv
exosom
multidrug
resist
protein
mirna
microrna
mrna
messeng
rna
mvb
multivesicular
bodi
pbodi
process
bodi
peg
poli
ethylen
glycol
pirna
piwiinteract
rna
risc
rnainduc
silenc
complex
rnai
rna
interfer
sirna
small
interfer
rna
vlp
viruslik
particl
vsvg
g
protein
vesicular
stomat
viru
review
part
advanc
drug
deliveri
review
theme
issu
exosom
key
deliv
genet
materi
associ
intern
transport
carrier
target
cell
depend
surfac
characterist
size
vesicl
taken
recipi
cell
via
differ
endocyt
rout
includ
clathrinor
caveolaedepend
endocytosi
macropinocytosi
phagocytosi
howev
rout
deliveri
uptak
ultim
lead
effect
function
cargo
releas
desir
intracellular
compart
rnaimedi
therapeut
via
natur
produc
nanovesicl
known
exosom
receiv
much
attent
appar
abil
incorpor
function
mirna
deliv
target
cell
howev
vesicl
select
specif
recipi
cell
vivo
remain
incomplet
understood
interestingli
exosom
releas
certain
viru
infect
cell
appear
equip
select
viral
product
modifi
potenti
enhanc
physiolog
function
exosom
may
thu
hold
critic
advantag
could
exploit
sirna
andor
mirna
target
deliveri
vivo
thu
knowledg
virus
exploit
exosom
may
aid
engin
potent
nanovehicl
specif
effici
deliveri
genet
materi
matur
late
endosom
le
limit
membran
endosom
start
bud
inward
result
format
isol
intralumin
vesicl
ilv
approxim
nm
size
special
type
endosom
known
multivesicular
bodi
mvb
ilv
function
presum
dynam
platform
select
sort
ubiquitin
nonubiquitin
cargo
destin
either
degrad
lysosom
recycl
fusion
mvb
lysosom
cargo
degrad
acid
environ
form
endolysosom
howev
ilv
deliv
lysosom
degrad
ilv
escap
degrad
instead
secret
extracellular
environ
upon
fusion
limit
membran
mvb
plasma
see
fig
allow
secret
ilv
exosom
recent
studi
indic
extracellular
membran
vesicl
endocyt
origin
interest
characterist
common
envelop
rna
virus
inde
like
retrovirus
exosom
incorpor
genet
materi
microrna
mirna
abl
deliv
neighbor
distal
cell
moreov
rna
content
deliv
specif
intracellular
site
recipi
cell
rnainduc
silenc
complex
risc
situat
import
role
epigenet
gene
regul
import
key
featur
exosom
prompt
high
interest
drug
deliveri
commun
properti
may
exploit
drug
deliveri
purpos
multivesicular
bodi
mvb
import
sort
molecul
degrad
pathway
exosom
secret
ubiquitin
attach
protein
target
signal
direct
cargo
ilv
lysosom
cargo
degrad
howev
cargo
also
exclud
ilv
recycl
transport
site
cellular
compart
endosom
sort
complex
requir
transport
escrt
involv
traffick
cargo
endosom
lysosom
degrad
four
distinct
escrt
known
name
escrti
escrtii
escrtiii
ii
recogn
ubiquityl
cargo
mvb
mark
fig
format
releas
virusmodifi
exosom
intralumin
vesicl
presum
precursor
exosom
form
inward
bud
lumen
multivesicular
bodi
mvb
process
intern
bud
lead
encapsul
cytoplasm
content
cell
origin
includ
host
andor
viral
compon
nucleic
acid
eg
small
noncod
rna
mrna
protein
eg
protein
situat
cytoplasm
membran
bound
protein
viral
glyco
protein
exact
mechan
nucleic
acid
packag
exosom
unclear
mayb
due
simpl
random
inclus
molecul
activ
select
packag
certain
nucleic
acid
speci
mirna
induc
exosom
releas
select
cargo
incorpor
evid
virusinfect
cell
releas
extracellular
environ
exosom
orient
cell
membran
shown
display
mani
surfac
marker
cell
origin
incorpor
viral
protein
exosom
appear
select
criterion
determin
exosom
faith
yet
defin
nucleu
n
epstein
barr
viru
ebv
sort
lysosom
escrtiii
play
role
concentr
cargo
recruit
deubiquityl
enzym
remov
ubiquitin
necessari
cargo
enter
ilv
cell
lack
escrt
protein
produc
fewer
mvb
ilv
fail
deliv
ubiquityl
cargo
lysosom
although
essenti
role
escrt
ilv
format
describ
yeast
wherea
mammalian
cell
ilv
form
escrtindepend
manner
sinc
simultan
knockdown
major
escrt
compon
complet
inhibit
mvb
biogenesi
ilv
format
furthermor
also
evid
exosom
secret
least
part
escrtindepend
lead
hypothesi
higher
eukaryot
use
escrt
system
togeth
escrtindepend
pathway
seem
driven
lipid
form
ilv
trajkov
et
al
demonstr
lipid
driven
pathway
may
select
cargo
protein
sort
requir
sphingolipid
ceramid
anoth
lipid
may
crucial
involv
ilv
format
phospholipid
lysobisphosphatid
acid
lbpa
lipidrich
domain
bend
inward
form
vesicl
way
lbpa
ceramid
coneshap
structur
thought
facilit
inward
transform
membran
seem
lipid
involv
format
ilv
mvb
escrt
mainli
involv
cargo
sort
current
unknown
molecular
mechan
behind
fusion
ilv
load
mvb
plasma
membran
snare
molecul
larg
evolutionari
conserv
famili
protein
involv
membran
tether
dock
fusion
snare
type
ii
membran
protein
highli
specif
dock
properti
vsnare
one
membran
interact
tsnare
opposit
membran
fusion
take
place
rab
small
transport
stepspecif
gtpbind
protein
tether
molecul
support
fusion
mvb
lysosom
plasma
membran
necessari
exosom
releas
exosom
first
describ
extern
membran
vesicl
origin
matur
reticulocyt
seen
method
cell
remov
obsolet
materi
subsequ
electronmicroscopi
studi
show
fusion
event
late
endosom
plasma
membran
multipl
hematopoiet
cell
type
suggest
content
mvb
releas
extracellular
space
exosom
due
origin
exosom
seen
special
type
microvesicl
confus
shed
vesicl
deriv
plasma
membran
inde
proteom
analysi
togeth
em
studi
strongli
suggest
ilv
intracellular
precursor
exosom
function
exosom
cellcel
commun
first
propos
raposo
et
al
show
exosom
b
cell
incorpor
transport
function
antigenpres
complex
know
exosom
releas
cell
type
includ
dendrit
cell
mast
cell
cell
b
cell
epitheli
cell
mesenchym
stem
cell
neuron
cell
mani
tumor
cell
although
exosom
one
sever
group
cellsecret
vesicl
rel
wellcharacter
defin
biophys
biochem
properti
compar
secret
membran
vesicl
exosom
typic
purifi
supernat
cultur
cell
ultracentrifug
nm
diamet
size
densiti
sucros
gml
proteom
analysi
demonstr
exosom
contain
defin
set
lipid
protein
carrier
nucleic
acid
includ
messeng
rna
mrna
noncod
micro
rna
mirna
see
fig
exosom
share
core
set
protein
lipid
content
extent
depend
cell
type
produc
specul
exosom
may
deriv
differ
mvb
subset
produc
distinct
subtyp
exosom
agreement
notion
studi
indic
two
exosom
protein
local
distinct
endosomelik
vesicl
mass
spectrometri
contribut
discoveri
differ
protein
identifi
exosom
whether
protein
contribut
function
remain
seen
seem
clear
conserv
protein
repertoir
exosom
across
celltyp
speci
exampl
endosom
protein
alix
identifi
major
exosom
studi
protein
content
thu
far
addit
heat
shock
protein
involv
protein
traffick
frequent
found
exosom
exosom
enrich
tetraspanin
like
import
molecul
proteinprotein
interact
cellular
membran
tetraspanin
bind
mani
protein
includ
integrin
mhc
molecul
specif
rab
protein
highli
conserv
famili
small
gtpase
function
molecular
switch
coordin
membran
traffic
often
observ
exosom
massspectrometri
exosom
also
rich
annexin
membran
traffick
protein
involv
fusion
event
furthermor
cytoskelet
protein
like
myosin
actin
tubulin
present
exosom
final
metabol
enzym
antigen
present
molecul
ribosom
protein
signal
transduct
molecul
shown
present
exosom
besid
select
set
protein
exosom
also
incorpor
function
nucleic
acid
notabl
small
rna
molecul
presum
due
close
intracellular
interact
riscassembl
complex
situat
endolysosm
membran
rna
molecul
detect
exosom
class
long
noncod
mirna
receiv
attent
sinc
discoveri
mirna
function
transfer
recipi
cell
mirna
regul
gene
express
bind
imperfectli
untransl
region
target
mrna
result
translat
repress
mrna
protein
mechan
somewhat
differ
sirna
mediat
gene
repress
sirna
perfectli
complementari
target
sequenc
result
mrna
degrad
essenc
mirna
regul
repress
gene
revers
sirna
mediat
repress
biogenesi
mirna
start
nucleu
transcript
dna
rna
polymeras
ii
primari
mirna
primirna
primirna
must
contain
hairpin
stem
loop
structur
approxim
basepair
critic
digeorg
syndrom
critic
region
gene
protein
bind
thereaft
primirna
cleav
premicro
rna
microprocessor
complex
form
rnase
iii
enzym
drosha
protein
form
premirna
export
nucleu
cytoplasm
complex
rangtp
premirna
cleav
nucleotid
mirna
dicertrbppact
complex
consist
rnase
iii
enzym
dicer
transactiv
respons
rnabind
protein
trbp
cellular
protein
pact
function
strand
load
rnainduc
silenc
complex
risc
argonaut
ago
protein
mirna
guid
risc
silenc
target
mrna
passeng
strand
howev
degrad
abil
exosom
incorpor
transfer
function
mirna
celltyp
specif
manner
drawn
much
attent
genetherapist
attract
altern
deliveri
therapeut
genet
materi
mode
entri
engulf
extern
materi
import
intracellular
compart
materi
direct
mani
virus
instanc
specif
entri
rout
defin
life
cycl
one
import
viru
either
avoid
direct
uptak
lysosom
process
call
endosom
escap
altern
choos
site
replic
equal
import
virus
replic
host
cell
nucleu
other
prefer
cytoplasm
other
replic
specif
organel
late
endosom
mvb
assembl
plasma
membran
littl
known
exosom
subset
thereof
may
enter
recipi
cell
suggest
occur
via
specif
lipid
ligandreceptor
interact
instanc
exosom
express
intercellular
adhes
molecul
bind
lymphocyt
functionassoci
antigen
express
dc
cell
furthermor
exosom
appear
carri
phosphatidylserin
bind
phosphatidylserin
receptor
like
cell
immunoglobulin
domain
mucin
domain
protein
addit
mhcii
posit
exosom
could
specif
target
cell
wherea
mhci
posit
exosom
may
target
cell
final
evid
select
galectin
carri
exosom
ebvinfect
b
cell
function
specif
receptor
tim
molecul
target
cell
despit
point
evid
much
learn
mechan
subtyp
exosom
genet
materi
transport
recipi
cell
whether
transport
function
appar
similar
exosom
certain
rna
virus
use
briefli
revisit
virus
target
cell
interest
discuss
whether
target
exosom
may
function
similar
way
enter
cell
overcom
intracellular
barrier
specif
deliveri
genet
materi
defin
cellular
compart
perhap
best
answer
studi
virus
multipli
virus
must
success
deliv
genom
host
cell
avoid
innat
immun
recognit
exploit
host
intracellular
machineri
replic
effici
viral
infect
depend
follow
sequenc
event
bind
cell
surfac
receptor
b
intern
pathway
cell
c
escap
endocyt
vesicl
deliveri
viral
genom
nucleu
enter
host
cell
virus
first
engag
specif
cellular
membran
protein
orand
receptor
induc
conform
chang
requir
facilit
viral
entri
attach
factor
proteoglycan
extracellular
matrix
protein
bind
virus
concentr
viru
particl
cell
surfac
nonspecif
way
howev
true
viru
receptor
involv
specif
bind
target
cell
ultim
receptor
determin
cell
type
infect
plethora
differ
surfac
receptor
entri
protein
fig
extracellular
exosom
express
defin
set
protein
lipid
deliv
small
noncod
rna
target
cell
exosom
leav
cell
origin
enter
blood
stream
bodili
fluid
taken
cell
mean
celltocel
commun
depend
target
strategi
bioengin
virusmodifi
exosom
destin
engag
cellspecif
receptor
exosom
taken
endocytosi
fuse
endosom
membran
releas
genet
cargo
cytoplasm
might
associ
rnai
risc
machineri
block
mrna
translat
protein
nucleu
n
attach
factor
virus
describ
exampl
adenovirus
use
coxsacki
adenoviru
receptor
car
primari
bind
receptor
integrin
coreceptor
close
interact
target
cell
wellknown
viral
entri
protein
exampl
haemagglutinin
initi
cell
entri
influenza
viru
bind
high
affin
sialic
acid
receptor
complement
receptor
b
cell
prime
target
viral
envelop
protein
epstein
barr
viru
ebv
combin
mhcii
use
coreceptor
thu
virus
interact
target
cell
effici
yet
specif
manner
ensur
open
defin
point
entri
allow
intracellular
voyag
toward
product
replic
whether
specif
also
exist
cellsecret
exosom
deliv
genet
cargo
remain
determin
virus
use
sever
distinct
endocyt
rout
intern
host
cell
clathrin
mediat
endocytosi
caveolar
endocytosi
clathrinand
caveolaeindepend
endocytosi
addit
virus
eg
herp
virus
retrovirus
paramyxovirus
seem
enter
cell
direct
fusion
plasma
membran
howev
improv
rapid
visual
techniqu
reveal
fusion
host
cell
membran
preced
receptormedi
intern
simplic
genom
deliveri
demonstr
less
sophist
virus
use
effici
method
releas
genom
cytosol
nonenvelop
adenovirus
enter
cell
classic
endocytosi
intern
virus
reloc
endosom
escap
acidif
degrad
lysosom
suitabl
condit
adenoviru
disrupt
endosom
membran
bind
extern
protein
lipid
bilay
endosom
caus
pore
format
releas
capsid
cytosol
viral
capsid
dock
nuclear
membran
deliv
viral
genom
replic
lysosom
escap
mechan
well
time
occur
decreas
ph
interestingli
envelop
virus
includ
hiv
also
fuse
endosom
membran
mediat
viral
releas
cytosol
thu
ultim
entri
site
occur
endosom
compart
plasma
membran
form
viral
fusion
endosom
sensit
dynamin
inhibitor
dynasor
suggest
infect
cell
dynamindepend
fusion
event
within
intracellular
endosom
compart
thu
virus
evolv
remark
strategi
enter
target
cell
avoid
lysosom
degrad
deadend
exogen
particl
enter
via
classic
endocyt
pathway
insight
intracellular
traffick
virus
may
thu
provid
rational
improv
deliveri
system
genet
materi
includ
synthet
vesicl
liposom
natur
occur
exosom
current
use
gene
deliveri
system
divid
roughli
two
group
viral
nonvir
vector
nonvir
vector
like
cation
liposom
less
toxic
immunogen
viral
vector
cation
liposom
improv
specif
gene
transfer
use
target
ligand
like
transferrin
improv
cellular
deliveri
cation
liposom
furthermor
endosom
escap
requir
transfer
function
sirna
mirna
facilit
lipid
dope
howev
specif
organ
tissu
target
vesicl
remain
big
hurdl
addit
short
lifetim
aggreg
cation
liposom
problemat
effici
deliveri
genet
materi
could
potenti
overcom
addit
poli
ethylen
glycol
peg
peg
modif
could
stabil
liposom
might
protect
sirna
serum
degrad
make
suitabl
rna
deliveri
although
yet
clinic
valid
one
promis
approach
combin
nonvir
viral
compon
thu
take
advantag
effici
target
deliveri
sirna
best
known
exampl
virosom
viruslik
particl
vlp
wherea
virosom
vesicl
consist
unilamellar
phospholipid
bilay
incorpor
viru
deriv
protein
allow
virosom
fuse
target
cell
vlp
made
transfect
product
cell
line
singl
plasmid
encod
viral
structur
protein
selfassembl
capsid
protein
gener
noninfecti
particl
pack
bioengin
cargo
vlp
produc
differ
virus
vlp
shown
success
transfer
nucleic
acid
howev
exhibit
limit
packag
capac
immunogen
one
interest
exampl
successfulcombinatori
method
coat
liposom
inactiv
hemagglutin
viru
japan
hvj
hvj
liposom
two
import
envelop
protein
involv
membran
fusion
fusion
introduc
dna
directli
cytoplasm
virus
hijack
endosom
pathway
endosom
machineri
benefit
produc
new
virion
product
stage
also
ingeni
mean
immunoevas
facilit
viral
spread
besid
modifi
proteom
genet
content
exosom
appear
virus
exploit
whole
rang
secret
vesicl
recent
review
meck
et
al
hiv
instanc
exploit
escrt
machineri
format
particular
exosomelik
vesicl
close
involv
viral
bud
plasma
membran
base
observ
trojan
hors
hypothesi
predict
retrovirus
mayb
packag
specif
within
exosomelik
coat
allow
stealthi
infect
modu
neighbor
cell
ie
without
use
envelop
glycoprotein
env
andor
retrovir
receptor
addit
exosom
releas
hiv
infect
cell
may
contain
coreceptor
transfer
neighboringrecipi
cell
may
enhanc
suscept
infect
hiv
promot
viral
spread
although
mani
detail
unknown
anoth
interest
observ
specif
releas
transport
hiv
nef
protein
neighbor
cell
via
exosom
nanotub
nef
abl
alter
endosom
system
altogeth
increas
number
endosom
lysosom
mvb
nef
wide
consid
hiv
virul
factor
one
mechan
mayb
secret
via
exosom
associ
induct
apoptosi
respond
cell
collect
observ
link
nef
exosom
hiv
pathogenesi
mean
stimul
immunoevas
studi
shown
ebv
encod
latent
membran
play
import
role
exosom
secret
infect
cell
potenti
oncoprotein
induc
constitut
activ
drive
continu
prolifer
latenc
type
iii
lymphoblastoid
b
cell
line
lcl
cell
vitro
avoid
overactiv
condit
associ
ebvassoci
lymphoma
nonebv
associ
diffus
larg
b
cell
lymphoma
rapidli
degrad
instead
escap
secret
via
exosom
occur
select
associ
tetraspanin
drive
sort
secret
via
exosom
importantli
secret
neg
effect
tcell
respons
help
infect
cell
escap
immun
respons
similar
observ
secret
nef
interestingli
protein
key
biochem
characterist
common
hivnef
protein
envelop
protein
specif
share
conserv
transmembran
domain
env
protein
carri
protein
class
retrovirus
sinc
mani
remark
similar
virus
exosom
suggest
viral
immun
evas
target
properti
could
use
artifici
nonvir
carrier
optim
target
cell
select
drug
deliveri
virusencod
envelop
protein
exhibit
superior
bind
entri
specif
efficaci
exosom
deliv
genet
materi
could
improv
incorpor
select
viral
protein
fact
natur
produc
exosom
releas
ebv
produc
cell
may
carri
viral
glycoprotein
surfac
line
find
vallhov
et
al
suggest
exosom
could
engin
select
target
posit
b
cell
introduc
exosom
produc
noninfect
cell
inde
proof
principl
author
show
cell
overexpress
ebv
encod
releas
exosom
carri
protein
specif
target
posit
b
cell
howev
caution
made
administ
exosom
vivo
also
express
cell
follicular
dc
nevertheless
engulf
exosom
leukem
blast
chronic
lymphocyt
leukemia
bcll
present
peptid
evok
ebvspecif
cell
redirect
strong
antivir
cellular
respons
toward
malign
bcell
one
could
specul
target
exosom
load
mirna
sirna
inhibit
function
activ
oncogen
bcll
might
power
cellspecif
therapeut
tool
like
addit
cell
follicular
dc
affect
therapeut
rna
sinc
cell
express
target
mrna
gb
envelop
protein
human
herp
viru
type
also
gain
access
lumin
vesicl
releas
via
exosom
observ
interpret
immuneevas
function
viru
divert
class
ii
molecul
effici
antigen
present
locat
within
cell
yet
primari
function
mediat
fusion
target
cell
thu
permit
viral
entri
thu
seem
attract
studi
gbdriven
exosom
target
uptak
suscept
cell
moreov
hepat
c
viru
hcv
envelop
glycoprotein
interact
human
tetraspanin
sort
exosom
hcv
complex
detect
blood
sampl
hcvpatient
suggest
yet
anoth
role
exosom
viral
pathogenesi
collect
studi
indic
dna
retrovirus
virus
highjack
endosomalexosom
pathway
exclus
product
life
cycl
also
purpos
evad
immun
respons
altern
modifi
exosom
carri
viral
protein
use
effect
vaccin
indic
safeti
approach
besid
incorpor
natur
produc
exosom
similar
scheme
attempt
relat
carrier
vesicl
instanc
incorpor
vesicular
stomat
virusencod
g
protein
vsvg
hivbas
viral
vector
enhanc
uptak
viruslik
particl
particl
dendrit
cell
similarli
incorpor
vsvg
coupl
antigen
ovalbumin
ova
exosomelik
vesicl
yield
elev
uptak
dendrit
cell
dc
engulf
modifi
exosom
show
enhanc
present
exosom
ova
antigen
induc
specif
ctl
respons
suggest
target
antigen
viral
fusion
protein
exosom
improv
exosom
vaccin
efficaci
viral
protein
exosom
vaccin
test
studi
kuat
et
al
show
exosomebas
vaccin
contain
protein
sar
coronaviru
induc
neutral
antibodi
titer
mani
similar
biochem
composit
biogenesi
cellular
releas
exosom
retrovirus
mention
studi
detail
led
hypothes
retrovirus
may
evolv
util
preexist
host
endosomalexosom
biogenesi
pathway
format
infecti
viru
egress
retrovirus
like
exosom
contain
rna
wherea
rna
retrovirus
make
entir
genom
exosom
may
contain
divers
popul
rna
molecul
includ
mirna
mrna
assembl
appear
take
place
late
endosom
membran
macrophag
cell
hiv
seem
preferenti
bud
plasma
membran
strikingli
even
assembl
hiv
plasma
membran
share
similar
endosom
bud
instanc
recruit
escrt
machineri
requir
effici
bud
fact
exosom
well
retrovirus
requir
high
level
cholesterol
glycosphingolipid
contain
common
glycan
coat
high
mannos
complex
nlink
glycan
suggest
similar
requir
particl
assembl
detect
endosom
marker
associ
macrophagederiv
virion
suggest
viral
assembl
bud
take
rout
similar
exosom
releas
mvb
inde
mvb
protein
like
e
class
protein
particip
hiv
bud
probabl
also
retro
virus
baretto
et
al
show
infect
epitheli
cell
rotaviru
rv
increas
releas
membran
vesicl
typic
exosom
marker
exosom
rvinfect
cell
show
higher
tcell
inhibit
exosom
noninfect
cell
howev
viral
product
detect
vesicl
clearli
suggest
content
exosom
rvinfect
cell
differ
exosom
noninfect
cell
similar
find
hivinfect
cell
indic
specif
incorpor
releas
hostencod
antivir
protein
abundantli
secret
via
exosom
addit
shown
ebvinfect
b
cell
secret
via
exosom
immunodulatori
properti
cell
dc
final
first
demonstr
virusinfect
cell
packag
virusencod
rna
exosom
deliv
noninfect
recipi
cell
specif
show
high
copi
number
ebv
encod
bartmirna
transport
via
exosom
function
multipl
recipi
cell
includ
primari
monocytederiv
dc
importantli
also
observ
transfer
subset
viral
mirna
infect
noninfect
cell
human
propos
exosom
may
design
deliv
small
rna
special
biogenesi
presum
entri
rout
observ
later
confirm
other
suggest
viral
factor
incorpor
appropri
deliveri
vesicl
endogen
produc
exosom
could
exploit
therapeut
rnaiapproach
increas
target
efficaci
rna
interfer
rnai
gene
silenc
process
cell
initi
small
rna
like
sirna
pirna
mirna
noncod
inhibitori
small
rna
believ
origin
innat
defens
mechan
viral
infect
soon
discov
introduct
small
rna
mammalian
cell
lead
specif
inhibit
gene
express
rais
possibl
rnai
could
exploit
vivo
target
diseasecaus
gene
howev
sirna
hydrophil
cross
membran
thu
nake
sirna
reach
target
tissu
vivo
moreov
sirna
short
halflif
circul
due
presenc
rnase
activ
blood
howev
chemic
synthes
sirna
vectorencod
sirna
may
improv
molecular
integr
vivo
result
stabl
deliveri
inde
bitko
et
al
show
pulmonari
infect
mice
caus
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
prevent
intranas
sirna
furthermor
rnai
inhibit
neuropath
pain
rat
diseas
model
inject
sirna
intrathec
inhibit
viral
replic
mani
virus
vitro
inhibit
surviv
growth
tumor
cell
resist
rnai
fight
viral
infect
document
indic
combinatori
approach
multipl
conserv
sequenc
like
requir
prevent
emerg
rnairesist
escap
virus
although
sirna
potenti
use
potent
therapeut
mani
diseas
deliveri
need
optim
optim
deliveri
small
hydrophil
sirna
still
remain
major
challeng
current
focu
prevent
prematur
degrad
sirna
serum
nucleas
improv
specif
cell
target
maxim
subsequ
rnai
load
risc
complex
target
cell
antibodi
molecul
use
deliv
sirna
specif
target
cell
via
cellsurfac
receptor
ligandassoci
sirna
also
recogn
specif
antigen
target
cell
taken
upon
bind
moreov
sever
deliveri
vesicl
like
nanoparticl
virus
liposom
use
prevent
degrad
sirna
serum
nucleas
attenu
viral
vector
also
frequent
use
sirna
deliveri
provid
stabl
sourc
nucleic
acid
rnai
machineri
howev
current
sirna
carrier
clear
preexist
antibodi
opsonin
complement
coagul
factor
furthermor
viral
vector
insert
viral
dna
chromosom
dna
caus
genet
dysregul
therefor
artifici
nonvir
vesicl
prefer
like
lipid
nanoparticl
appear
effici
sirna
deliveri
howev
liposom
lipid
nanoparticl
also
sensit
phagocytos
bind
opsonin
complement
factor
moreov
sirna
lipid
nanoparticl
easili
escap
endosom
necessari
load
sirna
cytoplasm
risc
complex
polymer
nanoparticl
escap
endosom
interact
serum
protein
increas
clearanc
furthermor
particl
caus
ruptur
endosom
enhanc
endosom
escap
also
lead
coreleas
cathepsin
b
strong
trigger
undesir
inflamm
polymer
nanoparticl
may
also
accumul
unintend
tissu
therebi
limit
effect
target
tissu
interest
limit
altern
effici
approach
still
need
develop
attract
altern
approach
safe
effici
sirna
deliveri
vivo
even
tissu
brain
use
endogen
cellproduc
exosom
nonvir
deliveri
vesicl
major
advantag
natur
produc
exosom
lipid
nano
particl
viralvector
appar
carri
function
sirna
andor
mirna
across
bloodbrain
barrier
rna
interfer
approach
treat
diseas
gain
much
momentum
recent
year
potenti
treat
rare
diseas
caus
singl
gene
cost
effect
manner
major
challeng
deliv
sirna
mirna
effect
target
tissu
propos
basic
knowledg
exosom
biogenesi
combin
detail
understand
viral
deliveri
strategi
may
one
day
overcom
challeng
illustr
eleg
studi
discuss
current
knowledg
natur
occur
rna
contain
vesicl
known
exosom
virus
seem
exploit
hope
rais
interest
use
vesicl
therapeut
rnai
deliveri
futur
still
much
learn
exosom
oper
vivo
method
action
specif
target
kinet
inde
larg
scale
exosom
product
isol
still
remain
challeng
ultracentrifug
time
consum
may
hamper
effort
use
exosom
vaccin
moreov
composit
exosom
fulli
elucid
especi
rna
level
thu
artifici
product
natur
occur
vesicl
complex
composit
may
difficult
origin
perceiv
howev
one
consid
hiv
genom
kb
packag
within
vesicl
similar
size
exosom
one
could
potenti
pack
copi
mirna
one
singl
exosom
balaj
et
al
estim
one
cell
may
produc
exosom
day
one
could
imagin
product
exosom
carri
suffici
therapeut
rna
molecul
certainli
feasibl
larg
scale
becom
appar
cell
secret
one
multipl
subpopul
exosom
probabl
consist
distinct
set
protein
lipid
sever
import
protein
like
tetraspanin
annexin
heat
shock
protein
found
exosom
may
core
function
howev
distinct
tetraspanin
may
play
import
role
target
cell
select
mani
detail
remain
unclear
viral
protein
mayb
use
enhanc
uptak
deliveri
exosom
specif
target
cell
elegantli
shown
recent
alvarez
et
al
importantli
exosom
alreadi
proven
biolog
relev
cancer
vaccin
wherebi
dendrit
cellderiv
exosom
use
induc
immun
respons
fulli
compat
idea
exosom
candid
deliveri
vehicl
therapeut
rna
addit
viru
modifi
exosom
seem
exhibit
potent
antiinflammatori
properti
fulli
understood
could
exploit
clinic
intrigu
possibl
target
mirna
deliveri
via
exosom
could
exploit
instanc
overcom
drug
resist
exampl
overproduct
abc
transport
document
caus
drug
resist
hepatocellular
carcinoma
hcc
resist
hcc
due
upregul
abc
transport
express
mediat
downregul
sever
tumor
suppressor
mirna
reintroduct
mirna
cancer
cell
may
restor
drug
sensit
cell
sinc
sever
virus
specif
target
liver
cell
stretch
engin
exosom
carri
virusderiv
target
molecul
specif
liver
cancer
epitheli
cell
carri
therapeut
mirna
cargo
conclus
tini
vesicl
may
big
futur
drug
deliveri
